Prosecution Insights
Last updated: July 17, 2026
Application No. 18/275,500

POLYESTER RESIN COMPOSITION, AQUEOUS DISPERSION, COATING COMPOSITION, AND COATING FILM

Non-Final OA §103§112
Filed
Aug 02, 2023
Priority
Feb 05, 2021 — JP 2021-017775 +1 more
Examiner
FANG, SHANE
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Toyobo Mc Corporation
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
1148 granted / 1505 resolved
+11.3% vs TC avg
Strong +19% interview lift
Without
With
+18.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
61 currently pending
Career history
1558
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
73.0%
+33.0% vs TC avg
§102
14.4%
-25.6% vs TC avg
§112
5.3%
-34.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1505 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION All the references cited in the International Search Report have been considered. None is anticipatory. The most pertinent of these references have been applied below. Election/Restrictions The applicant has elected Group I (claims 1-2 and 4-5) and 2,6-naphthalene dicarboxylic acid without indicating traverse, and no argument has been submitted. Applicant’s election in the reply is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.03(a)). This restriction is made FINAL. See previous action for the reasons of applying restriction. Claim Rejections - Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory obviousness-type double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); and In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on a nonstatutory double patenting ground provided the conflicting application or patent either is shown to be commonly owned with this application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. Effective January 1, 1994, a registered attorney or agent of record may sign a terminal disclaimer. A terminal disclaimer signed by the assignee must fully comply with 37 CFR 3.73(b). Claim(s) 1-2 and 4-5 is (are) rejected on the ground of nonstatutory obviousness-type double patenting as being unpatentable over claims 1-5 and 16 of copending Application No. 18/275491 This is a provisional obviousness-type double patenting rejection because the conflicting claims have not in fact been patented. ‘491 (claims 1-5 and 16) meets instant claims 1-2 and 4-5 in an anticipatory manner, because it discloses the claimed polyester composition: PNG media_image1.png 200 400 media_image1.png Greyscale PNG media_image2.png 200 400 media_image2.png Greyscale PNG media_image3.png 200 400 media_image3.png Greyscale PNG media_image4.png 200 400 media_image4.png Greyscale Claim(s) 1-2 and 4 is (are) rejected on the ground of nonstatutory obviousness-type double patenting as being unpatentable over claims 1-2 and 4 of copending Application No. 18/275492 This is a provisional obviousness-type double patenting rejection because the conflicting claims have not in fact been patented. ‘492 (claims 1-2 and 4-5) meets instant claims 1-2 and 4 in an anticipatory manner, because it discloses the claimed polyester composition: PNG media_image5.png 200 400 media_image5.png Greyscale PNG media_image6.png 200 400 media_image6.png Greyscale PNG media_image7.png 200 400 media_image7.png Greyscale Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 4 is rejected under 35 U.S.C. 112(d), as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 4 fails to further limit claim 1, because the recited acids appear to not to be species of the claimed unsaturated dicarboxylic acid of claim 1. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1 and 4-5 is (are) rejected under 35 U.S.C. 103(a) as being unpatentable over Kawakusu et al. (US 20150064378) in view of Wanprecht et al. (US 20060149019), both listed on IDS and ISR. As to claims 1 and 4-5, Kawakusu (abs., claims, examples, Tables) discloses a polyester composition for producing inner surface coatings/films for food containers (1-2), wherein the polyester comprising two or more acids including preferably 80 mol% of 2,6-naphthalenedicaroxylic acid (as to instant claim 4, for processability, stability, and retort/dent resistance) and fumaric or maleic acid (17-34) and two more diols including ethylene glycol (as to the claimed diol a of instant claim 1), 1-2-propylene glycol (as to the claimed diol c of instant claim 1), and 1,4-cyclohexane dimethanol (as to the claimed diol b of instant claim 1). The polyester shows an acid value of 0-200 eq/ton, overlapping with the range of instant claim 1. It has been found that where claimed ranges overlap ranges disclosed by the prior art, a prima facie case of obviousness exists - see MPEP 2144.05. Kawakusu does not explicitly teach including fumaric or maleic acid to the polyester. In the same area of endeavor of producing inner surface coatings/films for food containers (abs., claims, examples, 2) using a polyester with similar comonomers (15, 36-54), Wanprecht (36-49) discloses maleic acid (as to the claimed unsaturated acid of instant claim 1) is FDA-compliant diacid to USA code 21-175300 for low toxicity. Therefore, as to claims 1 and 4-5, it would have been obvious to one of ordinary skill in the art to have modified the polyester disclosed by Kawakusu and select the diacid component as 80 or more mol% of 2,6-naphthalenedicaroxylic acid and maleic acid in view of Wanprecht, because the resultant polyester would yield less toxicity and improved processability, stability, and retort/dent resistance. The resultant maleic acid would be 0-20 mol%, overlapping with the range of instant claim 1. It has been found that where claimed ranges overlap ranges disclosed by the prior art, a prima facie case of obviousness exists - see MPEP 2144.05. Claim(s) 2 is (are) rejected under 35 U.S.C. 103(a) as being unpatentable over Kawakusu et al. (US 20150064378) in view of Wanprecht et al. (US 20060149019) and in further view of Kajimaru et al. (US 20020061959), all listed on IDS and ISR. Disclosure of Kawakusu and Wanprecht is adequately set forth in ¶4 and is incorporated herein by reference. They are silent on branching. Kawakusu teaches adding trimethyolopropane (Table 1). In the same area of endeavor of producing coatings/films (abs., claims, examples, 1-4) using a polyester with similar comonomers (19-29), Kajimara (29) discloses adding trifunctional polyol, such as trimethyolopropane, to obtain excellent processibilities of the polyester coating/films. Therefore, as to claim 2, it would have been obvious to one of ordinary skill in the art to have modified the polyester disclosed by Kaner and further added with a trifunctional polyol of trimethyolopropane in view of Kajimaru, because the resultant polyester coating/films would yield improved processibilities. One of ordinary skill in the art would obviously recognize trimethyolopropane would inherently yield branching because of the trifunctional hydroxyl group, as acknowledged by instant pgpub [0050]. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHANE FANG whose telephone number is (571)270-7378. The examiner can normally be reached on Mon-Thurs. 8am-6pm. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached on 571.572.1302. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHANE FANG/Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Aug 02, 2023
Application Filed
Aug 23, 2023
Response after Non-Final Action
May 26, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12668664
SULFUR COPOLYMER AND METHOD FOR PREPARING THE SAME
3y 3m to grant Granted Jun 30, 2026
Patent 12668662
METHOD FOR PRODUCING MALEIMIDE POLYETHYLENE GLYCOL LIPID
3y 3m to grant Granted Jun 30, 2026
Patent 12668917
Method to Manufacture a Recyclable Textile Product and the Said Product
3y 3m to grant Granted Jun 30, 2026
Patent 12643977
CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT
3y 5m to grant Granted Jun 02, 2026
Patent 12643984
POLYSILAZANE COATING METHOD AND DEVICE
3y 5m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
95%
With Interview (+18.8%)
2y 5m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1505 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month